HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Fujita Selected Research

Neoplasm Metastasis (Metastasis)

1/2012G-CSF induces focal intense bone marrow FDG uptake mimicking multiple bone metastases from uterine cervical cancer: a case report and review of the literature.
3/2005Metastatic retinoblastoma of the maxilla and mandible.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Fujita Research Topics

Disease

21Neoplasms (Cancer)
01/2017 - 02/2000
8Inflammation (Inflammations)
01/2016 - 09/2001
8Carcinoma (Carcinomatosis)
04/2003 - 01/2000
7Heart Failure
08/2016 - 10/2000
7Infections
02/2009 - 07/2000
6Carcinogenesis
01/2017 - 07/2000
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2004 - 01/2000
6Ischemia
09/2001 - 09/2000
5Melanoma (Melanoma, Malignant)
01/2017 - 06/2000
5Stomach Neoplasms (Stomach Cancer)
06/2002 - 02/2000
5Pancreatitis
05/2001 - 02/2000
4Myocardial Infarction
10/2005 - 03/2001
4Necrosis
03/2004 - 02/2000
4Colonic Neoplasms (Colon Cancer)
11/2001 - 03/2000
3Pain (Aches)
01/2016 - 01/2012
3Hypersensitivity (Allergy)
01/2016 - 07/2001
3Asthma (Bronchial Asthma)
05/2013 - 09/2001
3Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2013 - 05/2007
3Atherosclerosis
09/2011 - 01/2000
3Disseminated Intravascular Coagulation
01/2004 - 07/2000
3Left Ventricular Dysfunction
03/2002 - 01/2001
3Hypertension (High Blood Pressure)
11/2001 - 10/2000
3Body Weight (Weight, Body)
09/2001 - 01/2000
3Stable Angina
08/2001 - 01/2000
3Adenoma (Adenomas)
07/2001 - 01/2000
3Adenocarcinoma
07/2001 - 02/2000
3Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
12/2000 - 03/2000
2Osteoporosis
07/2020 - 07/2000
2Massive Hepatic Necrosis
11/2018 - 02/2000
2Hemorrhage
11/2016 - 03/2001
2Neoplasm Metastasis (Metastasis)
01/2012 - 03/2005
2Autoimmune Diseases (Autoimmune Disease)
02/2009 - 07/2001
2Idiopathic Pulmonary Fibrosis
12/2004 - 02/2003
2Pulmonary Fibrosis (Fibrosing Alveolitis)
12/2004 - 01/2001
2Lung Injury
12/2004 - 05/2001
2Pulmonary Hypertension
03/2004 - 01/2001
2Pulmonary Emphysema
03/2004 - 01/2001
2Multiple Organ Failure (MODS)
01/2004 - 05/2001
2Esophageal Neoplasms (Esophageal Cancer)
04/2003 - 01/2001
2Colorectal Neoplasms (Colorectal Cancer)
11/2001 - 03/2000
2Coronary Stenosis (Coronary Artery Stenosis)
11/2001 - 01/2000
2Seizures (Absence Seizure)
07/2001 - 01/2001
2Infarction (Infarctions)
05/2001 - 03/2000
2Reperfusion Injury
04/2001 - 04/2001
2Hepatocellular Carcinoma (Hepatoma)
03/2001 - 03/2000
2Myocardial Ischemia (Ischemic Heart Diseases)
03/2001 - 01/2000

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
04/2008 - 02/2000
6beta CateninIBA
11/2001 - 03/2000
5CytokinesIBA
08/2011 - 02/2000
4LipopolysaccharidesIBA
11/2016 - 07/2000
4Complementary DNA (cDNA)IBA
09/2005 - 06/2000
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2004 - 10/2000
4Fatty Acids (Saturated Fatty Acids)IBA
11/2001 - 01/2001
4Pharmaceutical PreparationsIBA
02/2001 - 03/2000
3DNA (Deoxyribonucleic Acid)IBA
11/2018 - 10/2000
3HydrogelsIBA
12/2015 - 05/2001
3AntigensIBA
05/2013 - 07/2000
3Dacarbazine (DIC)FDA LinkGeneric
01/2004 - 07/2000
3Protein C InhibitorIBA
01/2004 - 07/2000
3IodineIBA
04/2003 - 01/2001
3Messenger RNA (mRNA)IBA
11/2001 - 07/2000
3SolutionsIBA
11/2001 - 01/2000
3AcidsIBA
11/2001 - 01/2001
3TCF Transcription FactorsIBA
11/2001 - 07/2000
3LipidsIBA
04/2001 - 03/2001
3EnzymesIBA
04/2001 - 01/2000
2Biological ProductsIBA
01/2017 - 07/2000
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2016 - 07/2008
2ElementsIBA
06/2016 - 11/2000
2PlasticsIBA
01/2016 - 01/2000
2Peptides (Polypeptides)IBA
12/2015 - 07/2001
2Apolipoproteins E (ApoE)IBA
09/2011 - 01/2000
2ApolipoproteinsIBA
09/2011 - 01/2000
2VaccinesIBA
08/2011 - 07/2001
2Interleukin-6 (Interleukin 6)IBA
05/2007 - 02/2000
2fas Receptor (CD95 Antigen)IBA
02/2004 - 07/2000
2Okadaic AcidIBA
02/2004 - 12/2002
2NF-kappa B (NF-kB)IBA
02/2004 - 05/2001
2Oxidants (Oxidizing Agents)IBA
12/2001 - 03/2001
2p38 Mitogen-Activated Protein KinasesIBA
12/2001 - 03/2001
2Iodine-123IBA
11/2001 - 09/2001
2GelatinIBA
09/2001 - 05/2001
2iodofiltic acidIBA
09/2001 - 01/2001
2Nonesterified Fatty Acids (NEFA)IBA
09/2001 - 04/2001
2fragile histidine triad proteinIBA
07/2001 - 02/2000
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2001 - 10/2000
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
05/2001 - 09/2000
2CeruletideIBA
05/2001 - 09/2000
2Phospholipases A2 (Phospholipase A2)IBA
04/2001 - 01/2001
2Phospholipids (Phosphatides)FDA LinkGeneric
04/2001 - 01/2001
2Cholesterol Esters (Cholesteryl Esters)IBA
03/2001 - 01/2000
2oxidized low density lipoproteinIBA
03/2001 - 01/2000
2Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2001 - 10/2000
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
11/2000 - 01/2000
2Taurocholic Acid (Sodium Taurocholate)IBA
09/2000 - 04/2000

Therapy/Procedure

9Therapeutics
08/2016 - 02/2000
3Radiotherapy
01/2012 - 01/2001
2Drug Therapy (Chemotherapy)
03/2005 - 01/2004
2Intravenous Injections
09/2001 - 08/2000
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
06/2000 - 01/2000